Serena Williams’ Super Bowl commercial, which was an ad promoting GLP-1 weight loss drugs and the telehealth company Ro, has been met with criticism online after it aired on Sunday. Williams said in ...
After accounting for 14% of all prescription drug spending in 2025, the blockbuster GLP-1 drug class is on track to continue rapid growth and alter pharmaceutical spending trends. For example, Eli ...
Women treated with GLP-1 for weight loss show significantly higher rates of weight loss compared with men, but notably, no significant differences are observed in a variety of other patient ...
A meta-analysis found that women lost more weight than men while taking a GLP-1 receptor agonist. Biological differences, such as estrogen levels and body composition, may explain why women respond ...
CHICAGO, Jan. 13, 2026 /PRNewswire/ -- Aon plc (AON) (NYSE: AON), a leading global professional services firm, today released updated findings from its multi-year study of U.S. commercial health ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Serena Williams' Super Bowl commercial, which was an ad promoting GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results